Clinical Study Identifies Personalized Treatment Options for Metastatic Non-Small Cell Lung Cancer With Plasma Proteome Testing
FORT MYERS, Fla., April 25, 2024. Florida Cancer Specialists& Research Institute, LLC (FCS) medical oncologist and hematologist Ernesto Bustinza-Linares, MD is co-author of a recent abstract published in the American Society of Clinical... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - April 25, 2024 Category: Pharmaceuticals Source Type: clinical trials
SNC115 Injections in Patients With Recurrent/Refractory Small Cell Lung Cancer and Lung Large Cell Neuroendocrine Carcinoma
Conditions: Recurrent/Refractory Small Cell Lung Cancer Lung Large Cell Neuroendocrine Carcinoma Interventions: Drug: SNC115 injection Sponsors: Shanghai Simnova Biotechnology Co.,Ltd.; Shanghai Chest Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2024 Category: Research Source Type: clinical trials
Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2
Conditions: Breast Cancer; Lung Cancer; Genito-Urinary Cancer; Colorectal Cancer; Gastric Cancer; Pancreatic Cancer; Liver Cancer; Head and Neck Cancer; Melanoma Interventions: Behavioral: Hello for Cancer game; Other: Table Topics game Sponsors: Milton S. Hershey Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2024 Category: Research Source Type: clinical trials
Osimertinib as Neoadjuvant Therapy in Patients With Resectable Stage II-IIIB EGFR-mutated Lung Squamous Cell Carcinoma
Conditions: Lung Cancer; Carcinoma, Squamous Cell Interventions: Drug: Osimertinib Sponsors: The First Affiliated Hospital of Guangzhou Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2024 Category: Research Source Type: clinical trials
A Web-based Program to Help Caregivers of Lung Patients Learn About Available Supportive Care Resources
Conditions: Stage II Lung Cancer; Stage III Lung Cancer; Stage IV Lung Cancer Interventions: Other: Support for Caregiver - Generic List; Other: Support for Caregiver - Personalized List; Other: Internet-Based Intervention - CONNECT; Behavioral: Patient Navigation Sponsors: Wake Forest University Health Sciences; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2024 Category: Research Source Type: clinical trials
A Study Comparing BL-B01D1 With Docetaxel in Patients With Unresectable Locally Advanced or Metastatic EGFR Wild-type Non-small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer Interventions: Drug: BL-B01D1; Drug: Docetaxel Sponsors: Sichuan Baili Pharmaceutical Co., Ltd.; Baili-Bio (Chengdu) Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2024 Category: Research Source Type: clinical trials
A Study Comparing BL-B01D1 With Platinum Based Chemotherapy in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer Interventions: Drug: BL-B01D1; Drug: Pemetrexed+Cisplatin or Carboplatin Sponsors: Sichuan Baili Pharmaceutical Co., Ltd.; Baili-Bio (Chengdu) Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2024 Category: Research Source Type: clinical trials
Clinical Study on the Prevention and Treatment of Postoperative Metastasis of Lung Cancer by Fuzheng Quxie Recipe
Conditions: Lung Cancer Interventions: Drug: Fuzheng Quxie Recipe Sponsors: Jianhui Tian Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2024 Category: Research Source Type: clinical trials
A Study to Evaluate the Combination of Platinum-pemetrexed Based Chemotherapy Plus Lorlatinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) With Exclusively Extracranial Disease Progression on Lorlatinib
Conditions: Non Small Cell Lung Cancer Metastatic; ALK Gene Mutation Interventions: Drug: Lorlatinib Sponsors: Centro di Riferimento Oncologico - Aviano Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
JMT101 in Combination With Osimertinib, Versus Cisplatin-pemetrexed in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Exon 20ins Mutations
Conditions: Local Advanced or Metastatic NSCLC Interventions: Drug: JMT101 Injection; Drug: Osimertinib tablet; Drug: Cisplatin injection; Drug: Pemetrexed injection Sponsors: Shanghai JMT-Bio Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
Radiation Therapy Followed by Tislelizumab and Anlotinib Aeoadjuvant/Adjuvant Therapy for Stage II-IIIA NSCLC
Conditions: Non-Small Cell Lung Cancer Interventions: Drug: Anlotinib Hydrochloride Capsule; Drug: Tislelizumab Injection; Radiation: Hypofractionated Radiotherapy Sponsors: Ji Yongling Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
InvestigatioN of a Smart Probe for Lung lEsion Characterization Using Impedance Technology
Conditions: Lung Cancer Interventions: Device: BioSpy System Sponsors: Sensome Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
A Study to Learn About How Food and Esomeprazole Affect the Level of BAY2927088 in the Blood When Taken Together in Healthy Participants
Conditions: Advanced Non-small Cell Lung Cancer; EGFR Mutation; HER2 Mutation; Healthy Volunteers Interventions: Drug: BAY2927088; Drug: Esomeprazole; Other: Food Sponsors: Bayer Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2024 Category: Research Source Type: clinical trials
A Smart Self-Management Support Programme (3S) to Improve Quality of Life in Lung Cancer Patients
Conditions: Lung Cancer Interventions: Behavioral: 3S intervention; Behavioral: GH information Sponsors: The University of Hong Kong; Queen Mary Hospital, Hong Kong; The Queen Elizabeth Hospital; United Christian Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2024 Category: Research Source Type: clinical trials
Engineering Tumor Infiltrating Lymphocytes Injection (GC203 TIL) for the Treatment of Advanced Malignant Solid Tumors
Conditions: Solid Tumor; Gynecologic Cancer; Breast Cancer; Gastrointestinal Cancer; Lung Cancer Interventions: Biological: Engineering Tumor Infiltrating Lymphocytes Sponsors: Shanghai Juncell Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
